LINE-1 retrotransposons are greatly hypomethylated throughout miPSCs, outside of some other transposable elements and the genome all round, and also harbor choice protein-coding gene recommends. We show that therapy using the LINE-1 inhibitor lamivudine does not hinder reprogramming as well as effectively prevents endogenous retrotransposition, as recognized through long-read genome